These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12003710)

  • 1. Neurogenic factors in renal hypertension.
    Campese VM; Krol E
    Curr Hypertens Rep; 2002 Jun; 4(3):256-60. PubMed ID: 12003710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney and the neurogenic control of blood pressure in renal disease.
    Campese VM
    J Nephrol; 2000; 13(3):221-4. PubMed ID: 10928299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).
    Ye S; Nosrati S; Campese VM
    J Clin Invest; 1997 Feb; 99(3):540-8. PubMed ID: 9022090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension.
    Ye S; Zhong H; Duong VN; Campese VM
    Hypertension; 2002 Jun; 39(6):1101-6. PubMed ID: 12052849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure.
    Campese VM; Ye S; Truong RH; Gamburd M
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):202-8. PubMed ID: 11967814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications.
    Campese VM
    Clin Exp Nephrol; 2003 Sep; 7(3):167-71. PubMed ID: 14586711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic factors and hypertension in chronic renal failure.
    Campese VM
    J Nephrol; 1997; 10(4):184-7. PubMed ID: 9377724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic factors and hypertension in renal disease.
    Campese VM
    Kidney Int Suppl; 2000 Apr; 75():S2-6. PubMed ID: 10828754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension.
    Ye S; Zhong H; Yanamadala S; Campese VM
    Hypertension; 2006 Aug; 48(2):309-15. PubMed ID: 16785328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system and chronic renal failure.
    Boero R; Pignataro A; Ferro M; Quarello F
    Clin Exp Hypertens; 2001; 23(1-2):69-75. PubMed ID: 11270590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity.
    Campese VM; Ye S; Zhong H
    Hypertension; 2002 Feb; 39(2 Pt 2):519-24. PubMed ID: 11882601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure.
    Ye S; Ozgur B; Campese VM
    Kidney Int; 1997 Mar; 51(3):722-7. PubMed ID: 9067904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.
    Campese VM; Kogosov E; Koss M
    Am J Kidney Dis; 1995 Nov; 26(5):861-5. PubMed ID: 7485145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.
    Neumann J; Ligtenberg G; Klein II; Koomans HA; Blankestijn PJ
    Kidney Int; 2004 May; 65(5):1568-76. PubMed ID: 15086894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.
    Ye S; Zhong H; Yanamadala V; Campese VM
    Am J Hypertens; 2002 Aug; 15(8):717-24. PubMed ID: 12160195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure.
    Campese VM; Mozayeni P; Ye S; Gumbard M
    J Nephrol; 2002; 15(4):407-13. PubMed ID: 12243372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain mechanisms of sympathetic activation in heart failure: Roles of the renin‑angiotensin system, nitric oxide and pro‑inflammatory cytokines (Review).
    Xu B; Li H
    Mol Med Rep; 2015 Dec; 12(6):7823-9. PubMed ID: 26499491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic overactivity in patients with chronic renal failure.
    Converse RL; Jacobsen TN; Toto RD; Jost CM; Cosentino F; Fouad-Tarazi F; Victor RG
    N Engl J Med; 1992 Dec; 327(27):1912-8. PubMed ID: 1454086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.